The Causal Effect of Vitamin D Binding Protein (DBP) Levels on Calcemic and Cardiometabolic Diseases: A Mendelian Randomization Study

PLoS Medicine

Volumn 11, Issue 10, 2014, Pages

  Leong, Aaron ^a,b   Rehman, Waheed ^a,b   Dastani, Zari ^a   Greenwood, Celia ^b,c   Timpson, Nicholas ^d   Langsetmo, Lisa ^b   Berger, Claudie ^b   Fu, Lei ^e,f   Wong, Betty Y L ^e,f   Malik, Suneil ^g   Malik, Rainer ^h   Hanley, David A ⁱ   Cole, David E C ^e,f   Goltzman, David ^b   Richards, J Brent ^a,b,j  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

^e UNIVERSITY OF TORONTO   (Canada)

^f SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^g PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^h LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

ⁱ UNIVERSITY OF CALGARY   (Canada)

^j KING'S COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; GLUCOSE; INSULIN; PARATHYROID HORMONE; VITAMIN D BINDING PROTEIN; 25-HYDROXYVITAMIN D; VITAMIN D;

AGED; ARTICLE; CALCIUM BLOOD LEVEL; CARDIOMETABOLIC DISEASE; CHEMOLUMINESCENCE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; GENOTYPING TECHNIQUE; HUMAN; INSTRUMENTAL VARIABLE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MENDELIAN RANDOMIZATION ANALYSIS; META ANALYSIS (TOPIC); METABOLIC DISORDER; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; VITAMIN BLOOD LEVEL; ANALOGS AND DERIVATIVES; BLOOD; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; GENETICS; HYPERTENSION; STROKE;

CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERTENSION; POLYMORPHISM, SINGLE NUCLEOTIDE; STROKE; VITAMIN D; VITAMIN D-BINDING PROTEIN;

EID: 84908336306     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001751     Document Type: Article

References (71)

1. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, et al. (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96: 1911–1930.
2. Holick MF, (2007) Vitamin D deficiency. N Engl J Med 357: 266–281.
3. Artaza JN, Mehrotra R, Norris KC, (2009) Vitamin D and the cardiovascular system. Clin J Am Soc Nephrol 4: 1515–1522.
4. Giallauria F, Milaneschi Y, Tanaka T, Maggio M, Canepa M, et al. (2012) Arterial stiffness and vitamin D levels: the Baltimore longitudinal study of aging. J Clin Endocrinol Metab 97: 3717–3723.
5. Lai H, Fishman EK, Gerstenblith G, Brinker JA, Tong W, et al. (2012) Vitamin D deficiency is associated with significant coronary stenoses in asymptomatic African American chronic cocaine users. Int J Cardiol 158: 211–216.
6. Takiishi T, Gysemans C, Bouillon R, Mathieu C, (2010) Vitamin D and diabetes. Endocrinol Metab Clin North Am 39: 419–446.
7. Thrailkill KM, Jo CH, Cockrell GE, Moreau CS, Fowlkes JL, (2011) Enhanced excretion of vitamin D binding protein in type 1 diabetes: a role in vitamin D deficiency? J Clin Endocrinol Metab 96: 142–149.
8. Hatse S, Lambrechts D, Verstuyf A, Smeets A, Brouwers B, et al. (2012) Vitamin D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome, and genetic determinants of vitamin D insufficiency. Carcinogenesis 33: 1319–1326.
9. Mondul AM, Weinstein SJ, Virtamo J, Albanes D, (2012) Influence of vitamin D binding protein on the association between circulating vitamin D and risk of bladder cancer. Br J Cancer 107: 1589–1594.
10. Theodoratou E, Palmer T, Zgaga L, Farrington SM, McKeigue P, et al. (2012) Instrumental variable estimation of the causal effect of plasma 25-hydroxy-vitamin D on colorectal cancer risk: a mendelian randomization analysis. PLoS ONE 7: e37662.
11. Stokes CS, Volmer DA, Grunhage F, Lammert F, (2013) Vitamin D in chronic liver disease. Liver Int 33: 338–352.
12. Mak G, Hanania NA, (2011) Vitamin D and asthma. Curr Opin Pulm Med 17: 1–5.
13. Chalmers JD, McHugh BJ, Docherty C, Govan JR, Hill AT, (2013) Vitamin-D deficiency is associated with chronic bacterial colonisation and disease severity in bronchiectasis. Thorax 68: 39–47.
14. Maxwell CS, Carbone ET, Wood RJ, (2012) Better newborn vitamin D status lowers RSV-associated bronchiolitis in infants. Nutr Rev 70: 548–552.
15. Marques CD, Dantas AT, Fragoso TS, Duarte AL, (2010) The importance of vitamin D levels in autoimmune diseases. Rev Bras Reumatol 50: 67–80.
16. Benrashid M, Moyers K, Mohty M, Savani BN, (2012) Vitamin D deficiency, autoimmunity, and graft-versus-host-disease risk: implication for preventive therapy. Exp Hematol 40: 263–267.
17. Levin AD, Wadhera V, Leach ST, Woodhead HJ, Lemberg DA, et al. (2011) Vitamin D deficiency in children with inflammatory bowel disease. Dig Dis Sci 56: 830–836.
18. Erten S, Altunoglu A, Ceylan GG, Maras Y, Koca C, et al. (2012) Low plasma vitamin D levels in patients with familial Mediterranean fever. Rheumatol Int 32: 3845–3849.
19. Fernandes de Abreu DA, Landel V, Feron F, (2011) Seasonal, gestational and postnatal influences on multiple sclerosis: the beneficial role of a vitamin D supplementation during early life. J Neurol Sci 311: 64–68.
20. Hirani V, (2012) Vitamin D status and pain: analysis from the Health Survey for England among English adults aged 65 years and over. Br J Nutr 107: 1080–1084.
21. Hirani V, Tull K, Ali A, Mindell J, (2010) Urgent action needed to improve vitamin D status among older people in England!. Age Ageing 39: 62–68.
22. Verboven C, Rabijns A, De Maeyer M, Van Baelen H, Bouillon R, et al. (2002) A structural basis for the unique binding features of the human vitamin D-binding protein. Nat Struct Biol 9: 131–136.
23. Safadi FF, Thornton P, Magiera H, Hollis BW, Gentile M, et al. (1999) Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J Clin Invest 103: 239–251.
24. Bikle DD, Siiteri PK, Ryzen E, Haddad JG, (1985) Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels. J Clin Endocrinol Metab 61: 969–975.
25. Nykjaer A, Dragun D, Walther D, Vorum H, Jacobsen C, et al. (1999) An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 96: 507–515.
26. Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, et al. (2010) Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 376: 180–188.
27. Ahn J, Yu K, Stolzenberg-Solomon R, Simon KC, McCullough ML, et al. (2010) Genome-wide association study of circulating vitamin D levels. Hum Mol Genet 19: 2739–2745.
28. Lu L, Sheng H, Li H, Gan W, Liu C, et al. (2012) Associations between common variants in GC and DHCR7/NADSYN1 and vitamin D concentration in Chinese Hans. Hum Genet 131: 505–512.
29. Muindi JR, Adjei AA, Wu ZR, Olson I, Huang H, et al. (2013) Serum vitamin D metabolites in colorectal cancer patients receiving cholecalciferol supplementation: correlation with polymorphisms in the vitamin D genes. Horm Cancer 4: 242–250.
30. Adams JS, Chen H, Chun R, Ren S, Wu S, et al. (2007) Substrate and enzyme trafficking as a means of regulating 1,25-dihydroxyvitamin D synthesis and action: the human innate immune response. J Bone Miner Res 22 (Suppl 2) V20–V24.
31. Chun RF, (2012) New perspectives on the vitamin D binding protein. Cell Biochem Funct 30: 445–456.
32. Gomme PT, Bertolini J, (2004) Therapeutic potential of vitamin D-binding protein. Trends Biotechnol 22: 340–345.
33. Lopez-Farre AJ, Mateos-Caceres PJ, Sacristan D, Azcona L, Bernardo E, et al. (2007) Relationship between vitamin D binding protein and aspirin resistance in coronary ischemic patients: a proteomic study. J Proteome Res 6: 2481–2487.
34. Gibson DS, Newell K, Evans AN, Finnegan S, Manning G, et al. (2012) Vitamin D binding protein isoforms as candidate predictors of disease extension in childhood arthritis. J Proteomics 75: 5479–5492.
35. Blanton D, Han Z, Bierschenk L, Linga-Reddy MV, Wang H, et al. (2011) Reduced serum vitamin D-binding protein levels are associated with type 1 diabetes. Diabetes 60: 2566–2570.
36. Rocchiccioli S, Andreassi MG, Cecchettini A, Carpeggiani C, L'Abbate A, et al. (2012) Correlation between vitamin D binding protein expression and angiographic-proven coronary artery disease. Coron Artery Dis 23: 426–431.
37. Gasparri C, Curcio A, Torella D, Gaspari M, Celi V, et al. (2010) Proteomics reveals high levels of vitamin D binding protein in myocardial infarction. Front Biosci (Elite Ed) 2: 796–804.
38. Baier LJ, Dobberfuhl AM, Pratley RE, Hanson RL, Bogardus C, (1998) Variations in the vitamin D-binding protein (Gc locus) are associated with oral glucose tolerance in nondiabetic Pima Indians. J Clin Endocrinol Metab 83: 2993–2996.
39. Szathmary EJ, (1987) The effect of Gc genotype on fasting insulin level in Dogrib Indians. Hum Genet 75: 368–372.
40. Fang Y, van Meurs JB, Arp P, van Leeuwen JP, Hofman A, et al. (2009) Vitamin D binding protein genotype and osteoporosis. Calcif Tissue Int 85: 85–93.
41. Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, et al. (2008) The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status. Cancer Epidemiol Biomarkers Prev 17: 1339–1343.
42. Caldwell JD, Jirikowski GF, (2013) Sex hormone binding globulin and corticosteroid binding globulin as major effectors of steroid action. Steroids 81: 13–16.
43. Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G, (2008) Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 27: 1133–1163.
44. Jackson SA, Tenenhouse A, Robertson L, (2000) Vertebral fracture definition from population-based data: preliminary results from the Canadian Multicenter Osteoporosis Study (CaMos). Osteoporos Int 11: 680–687.
45. Traylor M, Farrall M, Holliday EG, Sudlow C, Hopewell JC, et al. (2012) Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol 11: 951–962.
46. Estrada K, Styrkarsdottir U, Evangelou E, Hsu YH, Duncan EL, et al. (2012) Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet 44: 491–501.
47. Morris AP, Voight BF, Teslovich TM, Ferreira T, Segre AV, et al. (2012) Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 44: 981–990.
48. Ehret GB, Munroe PB, Rice KM, Bochud M, International Consortium for Blood Pressure Genome-Wide Association Studies (2011) et al. (2011) Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 478: 103–109.
49. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, et al. (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42: 105–116.
50. Yang J, Loos RJ, Powell JE, Medland SE, Speliotes EK, et al. (2012) FTO genotype is associated with phenotypic variability of body mass index. Nature 490: 267–272.
51. Schunkert H, Konig IR, Kathiresan S, Reilly MP, Assimes TL, et al. (2011) Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 43: 333–338.
52. Fan B, Lu Y, Genant H, Fuerst T, Shepherd J, (2010) Does standardized BMD still remove differences between Hologic and GE-Lunar state-of-the-art DXA systems? Osteoporos Int 21: 1227–1236.
53. Lu Y, Fuerst T, Hui S, Genant HK, (2001) Standardization of bone mineral density at femoral neck, trochanter and Ward's triangle. Osteoporos Int 12: 438–444.
54. Berger C, Goltzman D, Langsetmo L, Joseph L, Jackson S, et al. (2010) Peak bone mass from longitudinal data: implications for the prevalence, pathophysiology, and diagnosis of osteoporosis. J Bone Miner Res 25: 1948–1957.
55. Berger C, Greene-Finestone LS, Langsetmo L, Kreiger N, Joseph L, et al. (2012) Temporal trends and determinants of longitudinal change in 25-hydroxyvitamin D and parathyroid hormone levels. J Bone Miner Res 27: 1381–1389.
56. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rdet al. (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604–612.
57. Baum CF, Schaffer ME, Stillman S, (2003) Instrumental variables and GMM: estimation and testing. Stata J 3: 1–31.
58. Nordestgaard BG, Palmer TM, Benn M, Zacho J, Tybjaerg-Hansen A, et al. (2012) The effect of elevated body mass index on ischemic heart disease risk: causal estimates from a Mendelian randomisation approach. PLoS Med 9: e1001212.
59. Brion MJ, Shakhbazov K, Visscher PM, (2013) Calculating statistical power in Mendelian randomization studies. Int J Epidemiol 42: 1497–1501.
60. Greene-Finestone LS, Berger C, de Groh M, Hanley DA, Hidiroglou N, et al. (2011) 25-hydroxyvitamin D in Canadian adults: biological, environmental, and behavioral correlates. Osteoporos Int 22: 1389–1399.
61. Dastani Z, Berger C, Langsetmo L, Fu L, Wong BY, et al. (2014) In healthy adults, biological activity of vitamin D, as assessed by serum PTH, is largely independent of DBP concentrations. J Bone Miner Res 29: 494–499.
62. Powe CE, Evans MK, Wenger J, Zonderman AB, Berg AH, et al. (2013) Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med 369: 1991–2000.
63. Smith GD, Ebrahim S, (2003) ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 32: 1–22.
64. Brunner EJ, Kivimaki M, Witte DR, Lawlor DA, Davey Smith G, et al. (2008) Inflammation, insulin resistance, and diabetes—Mendelian randomization using CRP haplotypes points upstream. PLoS Med 5: e155.
65. Hartman JL, 4thGarvik B, Hartwell L, (2001) Principles for the buffering of genetic variation. Science 291: 1001–1004.
66. Colhoun HM, McKeigue PM, Davey Smith G, (2003) Problems of reporting genetic associations with complex outcomes. Lancet 361: 865–872.
67. Vimaleswaran KS, Cavadino A, Berry DJ, Jorde R, (2014) LifeLines Cohort Study Investigators (2014) et al. (2014) Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study. Lancet Diabetes Endocrinol 2: 719–729.
68. Vimaleswaran KS, Berry DJ, Lu C, Tikkanen E, Pilz S, et al. (2013) Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med 10: e1001383.
69. Reid IR, Bolland MJ, Grey A, (2014) Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis. Lancet 383: 146–155.
70. Pludowski P, Grant WB, Bhattoa HP, Bayer M, Povoroznyuk V, et al. (2014) Vitamin D status in central Europe. Int J Endocrinol 2014: 589587.
71. Lips P, Hosking D, Lippuner K, Norquist JM, Wehren L, et al. (2006) The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. J Intern Med 260: 245–254.